• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5498 | Ordered by Date (descending)
 1 2 3 ... 25 26 27 ... 53 54 55  

Deal: Collaboration or Financing	Date
MorphoSys–G7 Therapeutics: therapeutic antibodies, 201508– collab to develop therap ABs targeting GPCRs	2015-08-04
AdvanceCor–SEVERAL: investment, 201508 2nd financing round €2.2m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank + founders	2015-08-01
Amgen–Novartis: CNS drugs, 201508– collab ww developm + commercialisation drugs for Alzheimer’s + migraine	2015-08-01
Deutsche Biotech Innovativ–SEVERAL: investment, 201508–201511 capital increase €1.6m 49k new shares €33.5/share out of 596.4k shares on public offer	2015-08-01
Novartis–CSL: investment, 201507 acquisition $275m of Novartis influenza vaccine business by CSL Ltd	2015-07-31
Santhera–SEVERAL: investment, 201507–201508 capital increase $28.6m	2015-07-31
DSM–Evonik: animal feed, 201507– collab developm algae-based production of omega-3 fatty acids for animal nutrition	2015-07-29
Mereo BioPharma–Novartis: investment, 201507 Novartis receives equity stake in consideration for acquisition of 3 programmes from Novartis by Mereo	2015-07-29
Mereo BioPharma–SEVERAL: investment, 201507 financing round $118m from Woodford + Invesco Perpetual at launch of company	2015-07-29
Apogenix–R-Biopharm: cancer companion diagnostics, 201507– collab developm CDx for Apogenix’ CD95 ligand inhibitor APG101	2015-07-28
Boehringer–Hanmi: kinase inhibitor, 201507–201609 TERMINATED license to HM61713 ww excl KR + CN + HK with $50m upfront + $680m milestones + royalties	2015-07-28
Boehringer–Hikma: investment, 201507– acquisition of Roxane Labs $2.65b w $1.18m in cash + 40m new Hikma shares + addit $125m milestones	2015-07-28
Hikma–Boehringer: investment, 201507– acquisition 40m new shares £940m representing 16.71% as part of sale of Roxane by BI to Hikma	2015-07-28
MRC Technology–Univ Göttingen: therapeutic antibodies, 201507– collab developm ABs targeting amyloid beta 4-x for Alzheimer’s Disease	2015-07-28
Pieris–SEVERAL: investment, 201507 public offering $25m+$3.3m with 9.1m+1.2m new shares common stock $2.75/share	2015-07-28
Protembis–SEVERAL: investment, 201507 seed financing round 7-digit € incl Innovationsstarter Fonds + Geratherm + angel investors	2015-07-28
Leon-Nanodrugs–Albany Private Equity: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Albany Private Equity Holding	2015-07-27
Leon-Nanodrugs–CD-Venture: investment, 201507 financing round Series A 1st closing totalling €18.5m incl CD-Venture	2015-07-27
Leon-Nanodrugs–LifeCare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl LifeCare Partners	2015-07-27
Leon-Nanodrugs–MJR PharmJet: nanoparticle drug delivery technology, 201507 collab existent	2015-07-27
Leon-Nanodrugs–OTHER: investment, 201507 financing round Series A 1st closing totalling €18.5m incl non-disclosed German Family Office	2015-07-27
Leon-Nanodrugs–SEVERAL: investment, 201507 financing round Series A 1st closing €18.5m led by TVM Capital Life Science	2015-07-27
Leon-Nanodrugs–Signet Healthcare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Signet	2015-07-27
Leon-Nanodrugs–TVM: investment, 201507 financing round Series A 1st closing totalling €18.5m led by TVM Capital Life Science	2015-07-27
Merck (DE)–Celares: protein pegylation services, 201507– collab Merck Millipore offering PEG services tog with Celares GmbH	2015-07-27
Medigene–QVT: investment, 201507 QVT owns 15.6% of Medigene shares after capital increase	2015-07-25
Poxel–MacDougall Biomedical Communications: public relations, 201507 service existent IR + PR in EU + US	2015-07-24
Scienion–Anteo Technologies: protein microarray technology, 201507– collab developm protein microarray consumables using Mix&Go technology	2015-07-24
BeneChill–Odlander Fredrikson: investment, 201507 existent investment listed on HealthCap web site	2015-07-23
Merck (DE)–BioMed X: pharma research, 201507– collab Merck Serono extension funding two cancer research groups at BioMed X	2015-07-23
Cevec–SEVERAL: investment, 201507 financing round €4.5m from Peppermint + Creathor Venture + NRW.Bank + Investtodate et al	2015-07-22
Leukocare–LifeCare Partners: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors	2015-07-22
Leukocare–SEVERAL: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors	2015-07-22
Memo Therapeutics–SEVERAL: investment, 201507 financing round Series A CHF2.3m from Swiss investors incl EVA Basel + Redalpine + Zürcher Kantonalbank	2015-07-22
Merck (DE)–Genedata: bioinformatics, 201507– supply Merck Serono implements Genedata Biologics as workflow platform for biopharma RnD	2015-07-22
Allergan–Molecular Partners: ophthalmics, 201507– collab expansion of DARPin alliance in ophthalmology	2015-07-21
Anagnostics–Cube Dx: investment, 201507 acquisition of all assets of Anagnostics Bioanalysis GmbH by Cube Dx GmbH	2015-07-21
Medigene–Aviva: investment, 201507 acquisition 1.97m shares by Aviva plc representing 10.01% of Medigene shares after capital increase	2015-07-20
BioAnalytica GenoType–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services	2015-07-16
Bioarray (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services	2015-07-16
Cialab (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services	2015-07-16
Genetadi Biotech–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services	2015-07-16
Genycell–Sophia Genetics: bioinformatics, 201507– distribution of Sophia DDM platform for clinical NGS data analysis in Iberia by Genycell	2015-07-16
Immunocore–Credit Suisse: investment banking, 201507 supply service Credit Suisse is advisor on $320m Series A round	2015-07-16
Immunocore–Malin Corp: investment, 201507 financing round Series A totalling $320m (£205m) incl new investor Malin Corp plc	2015-07-16
Immunocore–SEVERAL: investment, 201507 financing round Series A $320m (£205m) private from new + existing investors	2015-07-16
Piqur Therapeutics–SEVERAL: investment, 201507 financing round Series A2 CHF18m incl returning investor Versant Ventures	2015-07-16
Piqur Therapeutics–Versant Ventures: investment, 201507 financing round Series A2 totalling CHF18m incl returning investor Versant Ventures	2015-07-16
Accurate Mass Scientific–CovalX: mass spectrometry, 201507– collab AMS new Australian distributor of CovalX High-Mass systems + CRO analytics services	2015-07-15
Canbridge Life Sciences–Apogenix: cancer drug, 201507– license developm + commercialisation of APG101 in Greater China	2015-07-15
AdvanDx–OpGen: investment, 201507 merger acquisition by AdvanDx for 682k shares of OpGen common stock	2015-07-14
Volution Immuno Pharmaceuticals–Celsus Therapeutics: investment, 201508– reverse merger acqu of VIP by Celsus to be renamed Akari Therapeutics	2015-07-13
Apceth–Univ Cologne: T-cell immunotherapy, 201507– collab with CMMC use of MSCs for local activation of CAR T-cells within tumours	2015-07-10
Insilico Biotechnology–SEVERAL: investment, 201507 capital increase	2015-07-10
SGS–Northern Exposure PR: public relations, 201507 service existent for SGS Life Sciences by NEPR	2015-07-10
JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries	2015-07-09
JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF	2015-07-09
JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT	2015-07-09
InSphero–HP Wild Holding: investment, 201507 Series C financing CHF20m from HP Wild Holding AG	2015-07-08
Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system	2015-07-08
Cassiopea–Cosmo Pharmaceuticals: investment, 201507 existent 45.4% shareholder after spin-off of Cassiopea from Cosmo via IPO at SIX	2015-07-06
Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech	2015-07-02
Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany	2015-07-02
Actelion–Qlucore: bioinformatics, 201507– license 3y to Omics Explorer s/w after using it since 2011	2015-07-01
Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG	2015-07-01
GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners	2015-07-01
GNA Biosolutions–SEVERAL: investment, 201507 financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH	2015-07-01
Seres Therapeutics–Nestlé: investment, 201507 equity investment by Nestlé Health Science	2015-07-01
TAmiRNA–EU (govt): grant, 201507– Horizon 2020 SME Instrument Phase I Funding for collab with IPF Vienna	2015-07-01
Spinifex Pharmaceuticals–Novartis: investment, 201506– acquisition €na ANNOUNCED	2015-06-29
Actelion–Max Planck: vaccine technology, 201506 license excl synthetic carbohydrate vaccines for new Vaxillion joint venture from + with Max Planck	2015-06-26
Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics	2015-06-26
Vaxxilon–Actelion: investment, 201506 founding w Max Planck + Actelion as majority owner w committed funding of €30m over 4y in tranches	2015-06-26
BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation	2015-06-25
BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG	2015-06-25
Gladstone Institutes–Thermo Fisher: grant, 201506– sponsoring of new Thermo Fisher Proteomics Facility for Disease Target Discovery at Gladstone	2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply Orbitrap Fusion Tribrid system to new Proteomics Facility at Gladstone	2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply TSQ Quantiva Triple Quad LC/MS system to new Proteomics Facility at Gladstone	2015-06-24
Thermo Fisher–Gladstone Institutes: mass spectrometry, 201506– collab establ new Thermo Fisher Proteomics Facility at Gladstone in collab w UCSF + QB3	2015-06-24
Ankasa Regenerative–Avalon Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A led by Avalon Ventures	2015-06-23
Ankasa Regenerative–Correlation Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Correlation	2015-06-23
Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical	2015-06-23
Ankasa Regenerative–SEVERAL: investment, 201506 financing round Series A 1st tranche $8.5m of planned $17m Series A led by Avalon Ventures	2015-06-23
ViraTherapeutics–Austria (govt): investment, 201506 financing round Series A 1st closing totalling €3.6m incl co-investor aws	2015-06-23
ViraTherapeutics–Boehringer: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures	2015-06-23
ViraTherapeutics–EMBL: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures	2015-06-23
ViraTherapeutics–SEVERAL: investment, 201506 financing round Series A 1st closing €3.6m co-led by BIVF + EMBL Ventures	2015-06-23
4SC–SEVERAL: investment, 201506–201507 cash capital increase €29m (net €27.5m) with 7.25m new shares at €4/share	2015-06-22
4SC–Strüngmann Group: investment, 201506–201507 capital increase €6m in kind 1.5m new shares at €4/share swapping part of shareholder loan from Santo	2015-06-22
4SC–Wellington Partners: investment, 201506–201507 cash capital increase totalling €29m incl €5m from Wellington	2015-06-22
Univ California–Scienion: automated liquid handling, 201506 supply existent Gianneschi Group at UCSD is early user of sciTEM system	2015-06-22
ChemAxon–BSSN Software: cheminformatics, –201506 collab developm Mass Spec Add-on for Instant JChem using Seahorse Scientific Workbench s/w platform	2015-06-18
Pierre Fabre–Biomax: bioinformatics, 201506– license to BioXM Knowledge Management Environment + collab database development	2015-06-18
Qiagen–Hitachi: genomic testing systems, 201506– collab strategic alliance €na developm PCR + NGS based automation systems for research + IVD	2015-06-18
IntelliCyt–Genedata: drug screening software, 201506– collab product integration of Genedata Screener s/w with iQue Screener system	2015-06-17
Pierre Fabre–Affimed: antibody technology, 201506– collab expansion 3y €na use AbCheck’s AbSieve+AbAccel techn to discover ABs against targets of CIPF	2015-06-17
Affiris–MIG Fonds: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds	2015-06-16
Affiris–SEVERAL: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds	2015-06-16
Affiris–Strüngmann Group: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds	2015-06-16
Debiopharm–Spinomix: sample processing technology, 201506 acquisition €na of FibroTrap technology by Debiopharm International SA	2015-06-16

 1 2 3 ... 25 26 27 ... 53 54 55  

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.